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DCs redirect T cell trafﬁc
 
Dendritic cells (DCs) are the master regulators of T cell 
recirculation, according to a study by Mora et al. on 
page 303. Memory T cells—thought to be programmed 
to return to the location in which they first 
encountered antigen—can be rerouted by an encounter 
with a DC from another location.
Previous studies have shown that memory T cells 
express a characteristic array of adhesion molecules 
and chemokine receptors on their surface that reflect 
the location of activation and direct their trafficking 
back to that site. Recently, this group showed that gut 
DCs, but not spleen or peripheral lymph node DCs, 
induced the up-regulation of the gut-homing integrin 
 
 
 
4
 
 
 
7 on T cells.
Mora et al. now show that these “committed” T 
cells are not set in their ways. In vitro, T cells 
stimulated with skin-derived DCs and later restimulated with gut-derived DCs 
quickly replaced their skin-homing molecules with the gut-homing variety 
(and vice versa), demonstrating that recirculating T cells simply obey the 
signals provided by the most recently encountered DC. In vivo, tissue-specific 
effector–memory T cells can revert to central–memory status, thus acquiring 
the capacity to home to a variety of second lymphoid tissue where they can 
encounter new instructions from resident DCs.
This plasticity may be important, points out senior author Ulrich von 
Andrian, as it would allow the immune system to fight off pathogens that can 
colonize more than one site. It might also provide a new approach to treating T 
cell–mediated inflammatory diseases, if harmful T cells can be diverted to an 
innocuous site.
T cell trafficking 
patterns can be changed 
after encounter with a 
dendritic cell from a 
new location.
 
Surviving rapamycin
 
T cell survival in the face of the immuno-
suppressive drug rapamycin depends on
the expression of prosurvival proteins
Pim-1 and Pim-2, according to a report
by Fox et al. on page 259. Pim-1 and
Pim-2 transmit signals that compensate
for those that are wiped out by rapamycin;
without the Pim proteins, rapamycin
is deadly.
Rapamycin, a drug used to pre-
vent rejection of transplants in humans,
blocks the activation of a protein kinase
called TOR (target of rapamycin), a
component of a T cell signaling pathway
that is important for cell survival and
activation. Rapamycin works in trans-
plant patients, but treatment of T cells
with this drug in vitro or elimination of
a signaling protein upstream of TOR in
mice has little effect on T cell activation
or survival. This paradox, says senior
author Craig Thompson, is “rapamycin’s
failed in two respects: they did not turn
on activation signals in response to
TCR ligation and they were unable
to respond to cytokine-driven survival
signals. Wild-type cells, however, acti-
vated the TCR pathway and survived
as well as untreated cells. Thus, the Pim
proteins provide the only alternative
signaling pathway that can bypass the
defect inflicted by rapamycin.
The debilitating consequences of
lacking Pim-1 and Pim-2 are in part due
to an inability to phosphorylate and thus
inactivate the proapoptotic protein Bad.
Without the Pim proteins, Bad runs
rampant. Whether activated Bad is the
sole cause of the effects seen in the absence
of Pim-1 and Pim-2 is not yet known,
but future studies using Bad-deficient
mice will reveal if other mechanisms
are also at play. Why rapamycin works
in patients who have no known de-
fects in the Pim proteins remains a
mystery.
 
dirty little secret.” The new work es-
tablishes the mechanism behind half of
this secret.
Thompson’s group now shows that
rapamycin’s lack of effect in vitro and in
mice is due to the expression of protein
kinases Pim-1 and Pim-2, which are
activated by growth-promoting cytokines
and TCR ligation. T cells lacking both
Pim proteins and treated with rapamycin
Pim-1 and Pim-2 are essential for T cell 
growth and survival in the presence of 
rapamycin.
 
UV-induced T
 
reg
 
 cells
 
A new study explains how UV ex-
posure induces immunosuppres-
sion. Previous studies showed that
UV-induced immunosuppression is
caused by regulatory T cells (T
 
reg
 
cells). On page 173, Schwarz et al.
now show that the development of
T
 
reg
 
 cells requires DNA damage to
DCs called Langerhans cells (LCs).
Mice exposed to UV light are
rendered unresponsive to antigens
applied to skin because of the in-
duction of T
 
reg
 
 cells, which interfere
with activation of effector T cells in
response to antigen. IL-12, a cytokine
produced by LCs, can both prevent
the establishment of the unresponsive
state and can also reverse established
tolerance  when provided in com-
bination  with  antigen stimulation.
Schwarz et al. showed in a previous
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